Kaplan L

Biography

 Les Kaplan, PhD, was recently the Executive Chairman of Aciex Therapeutics, Inc., a private, US-based, ophthalmic development pharmaceutical company, acquired by Nicox in October 2014. Previously he was Executive Vice President of Allergan, Inc. Dr. Kaplan joined Allergan in 1983 and, prior to being appointed to Executive Vice President, was Corporate Vice President, and President, Research and Development, and Global BOTOX from June 1998 to November 2003. He was elected to Allergan’s board of directors in 1994. Dr. Kaplan is a director of ACADIA Pharmaceuticals Inc and Neurotech. He also serves as a member of the board of directors of the Clinical Research Institute of the Foundation for Fighting Blindness. Dr. Kaplan received a PhD in organic chemistry from the University of California (Los Angeles, United States).  Les Kaplan, PhD, was recently the Executive Chairman of Aciex Therapeutics, Inc., a private, US-based, ophthalmic development pharmaceutical company, acquired by Nicox in October 2014. Previously he was Executive Vice President of Allergan, Inc. Dr. Kaplan joined Allergan in 1983 and, prior to being appointed to Executive Vice President, was Corporate Vice President, and President, Research and Development, and Global BOTOX from June 1998 to November 2003. He was elected to Allergan’s board of directors in 1994. Dr. Kaplan is a director of ACADIA Pharmaceuticals Inc and Neurotech. He also serves as a member of the board of directors of the Clinical Research Institute of the Foundation for Fighting Blindness. Dr. Kaplan received a PhD in organic chemistry from the University of California (Los Angeles, United States).

Research Interest

 Ophthalmology, Pharmaceuticals